文献速递前列腺增生与排尿功能障碍

新型组织工程口腔黏膜移植物用于前尿道成形术:手术技术与结局

Anterior Urethroplasty Using a New Tissue Engineered Oral Mucosa Graft: Surgical Techniques and Outcomes.
PubMed 文献 · J Urol · 2018-03-28

这项多中心回顾性研究纳入38例复发性前尿道狭窄患者,取0.5 cm²口腔黏膜活检制备组织工程MukoCell®移植物,3周后采用四种标准技术行前尿道成形术。中位随访55个月,治疗成功32/38例(84.2%),未见工程材料相关局部或全身不良反应。

要点

  • 组织工程口腔黏膜移植物可按前尿道成形术标准技术植入。
  • 38例复发性狭窄患者治疗成功率为84.2%,失败率15.8%。
  • 中位随访55个月,未见工程材料相关局部或全身不良反应。

核心结论

  • 组织工程口腔黏膜移植物可采用与自体口腔黏膜相同的前尿道成形术技术植入,并保证相似的成功率。

研究设计与样本

  • 多中心回顾性研究,纳入38例复发性前尿道狭窄患者,排除尿道下裂失败、硬化性苔藓、创伤性及后尿道狭窄者。
  • 取患者颊部0.5 cm²口腔黏膜活检,实验室制备组织工程MukoCell®移植物,3周后送院手术。
  • 采用腹侧覆盖、背侧覆盖、背侧嵌入及联合技术四种术式,术后1个月行膀胱尿道造影。

主要发现

  • 38例患者中位年龄57岁,狭窄位于阴茎段3例(7.9%)、球部29例(76.3%)、阴茎球部6例(15.8%)。
  • 中位狭窄长度5 cm,中位随访55个月。
  • 治疗成功32/38例(84.2%),失败15.8%。
  • 各术式成功率:腹侧覆盖85.7%、背侧覆盖83.3%、背侧嵌入80%、联合技术100%。
  • 未见工程材料相关局部或全身不良反应。

关键数值与推荐

  • 术后每6个月行临床评估、尿流率及残余尿测定。
  • 出现梗阻症状(最大尿流率小于12 ml/s)时重复尿道造影。
  • 因复发性狭窄接受进一步治疗者归类为治疗失败。

临床怎么用

  • 对复发性前尿道狭窄、且排除尿道下裂失败、硬化性苔藓、创伤及后尿道狭窄者,可考虑组织工程口腔黏膜移植物行前尿道成形术。
  • 可按腹侧覆盖、背侧覆盖、背侧嵌入或联合技术植入,无需改变标准术式。
  • 术后以尿流率小于12 ml/s作为触发尿道造影的梗阻阈值,并每6个月随访。

局限性

  • 回顾性多中心设计,样本量38例,证据级别有限。
  • 排除尿道下裂失败、硬化性苔藓、创伤性及后尿道狭窄,结果不能外推至这些人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated whether tissue engineered material may be adopted using standard techniques for anterior urethroplasty. MATERIALS AND METHODS: We performed a retrospective multicenter study in patients with recurrent strictures, excluding those with failed hypospadias, lichen sclerosus, traumatic and posterior strictures. A 0.5 cm2 oral mucosa biopsy was taken from the patient cheek and sent to the laboratory to manufacture the graft. After 3 weeks the tissue engineered oral mucosal MukoCell® graft was sent to the hospital for urethroplasty. Four techniques were used, including ventral onlay, dorsal onlay, dorsal inlay and a combined technique. Cystourethrography was performed 1 month postoperatively. Patients underwent clinical evaluation, uroflowmetry and post-void residual urine measurement every 6 months. When the patient showed obstructive symptoms, defined as maximum urine flow less than 12 ml per second, the urethrography was repeated. Patients who underwent further treatment for recurrent stricture were classified as having treatment failure. RESULTS: Of the 38 patients with a median age of 57 years who were included in study the strictures were penile in 3 (7.9%), bulbar in 29 (76.3%) and penobulbar in 6 (15.8%). Median stricture length was 5 cm and median followup was 55 months. Treatment succeeded in 32 of the 38 patients (84.2%) and failed in 15.8%. Success was achieved in 85.7% of ventral onlay, 83.3% of dorsal onlay, 80% of dorsal inlay and 100% of combined technique cases. No local or systemic adverse reactions due to the engineered material were noted. CONCLUSIONS: Our findings show that a tissue engineered oral mucosa graft can be implanted using the same techniques suggested for anterior urethroplasty and native oral mucosa, and guaranteeing a similar success rate.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Barbagli G, Akbarov I, Heidenreich A, et al. Anterior Urethroplasty Using a New Tissue Engineered Oral Mucosa Graft: Surgical Techniques and Outcomes. J Urol. 2018. PMID: 29601924. doi:10.1016/j.juro.2018.02.3102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。